Details of the Drug Reposition

General Information of This Drug (ID: DMZJNHM)

Drug Name	SYNB1891 DMZJNHM

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Neoplasm	DISZKGEW	2A00-2F9Z	Phase 1	[1]
Lymphoma	DISN6V4S	2A80-2A86	Phase 1	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT04167137) Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Subjects. U.S. National Institutes of Health.